Chemkart India IPO GMP | Price Band, Lot Size, GMP & Listing Updates 2025

Chemkart India IPO GMP

Chemkart India Limited, a B2B distributor of food, health, and sports nutrition ingredients, has launched its SME IPO and is gaining attention among retail and HNI investors. From product innovation to a growing market footprint, Chemkart is emerging as a niche player in India's nutrition and food tech sector. In this blog, we’ll explore the Chemkart India IPO, its GMP, price details, lot size, subscription trends, and listing updates.

Chemkart India IPO GMP Today

As of the latest update, the Chemkart India IPO GMP (Grey Market Premium) stands at ₹0. This neutral GMP suggests that while investor sentiment is stable, the IPO is being watched closely for future movement, especially around subscription levels.

???? IPO Price Band & Lot Size

• Price Band: ₹236 – ₹248 per share

• Lot Size: 600 shares

• Minimum Investment (1 lot): ₹1,48,800 (at upper band)

• Face Value: ₹10 per equity share

This pricing places Chemkart among fairly valued SME IPOs, especially considering its recent revenue scale and consistent profitability.

IPO Timeline

About Chemkart India Limited

Founded to simplify the B2B supply chain for nutrition and food-based ingredients, Chemkart India Limited operates in a high-growth niche. The company offers products like:

• Amino acids

• Herbal extracts

• Vitamins & minerals

• Proteins & sports nutrition raw materials
  
  

It has a 28,000+ sq. ft. facility in Bhiwandi for blending, packing, and private labeling — catering to startups and global food/nutrition brands across India.

 IPO Objective

The company plans to use IPO proceeds for:

• Working capital requirements

• Warehouse expansion

• Equipment upgrade

• General corporate purposes

This reflects Chemkart’s intent to scale operational capacity and strengthen its logistics infrastructure.

Subscription Status

On Day 1, the Chemkart India IPO subscription saw steady interest, particularly from retail investors. Subscription status is likely to grow as we approach the final day, with investors evaluating the fundamentals and the grey market trend.

Should You Subscribe to Chemkart India IPO?

Chemkart India’s IPO stands out due to its niche sector, growing client base, and robust warehousing setup. However, the GMP of ₹0 signals a wait-and-watch approach from the grey market. If you're a long-term investor confident in India’s health & nutrition ecosystem, Chemkart India IPO could be a calculated entry.

Chemkart India’s Industry Position and Long-Term Potential

India’s health and nutrition market has witnessed exponential growth over the past few years, driven by rising awareness, lifestyle changes, and demand for clean-label, protein-rich, and immunity-boosting products. In this expanding market, Chemkart India Limited has carved a unique position as a B2B distributor of high-quality raw ingredients for supplements, nutraceuticals, sports nutrition, and functional foods. The company’s robust sourcing model and global supplier network allow it to deliver competitively priced, authentic ingredients to brands of all sizes — from startups to established FMCG giants.

Additionally, with its own warehousing and blending facilities in Bhiwandi, Maharashtra, Chemkart ensures quality control and fast turnaround, giving it an operational edge. As the demand for private-label health supplements grows, Chemkart is well-placed to benefit from increased order volumes and recurring business. Investors looking at SME IPOs with long-term potential should note that the health ingredients industry is expected to grow at a CAGR of over 10% in the coming years. If the company continues to scale responsibly and maintain client trust, the Chemkart India IPO could offer more than just short-term listing gains — it could be a gateway into India’s evolving health economy.

Conclusion

The Chemkart India IPO GMP brings a strong B2B model, sectoral relevance, and operational scalability to the SME space. While GMP remains flat for now, its fundamentals and strategic vision make it worth evaluating. For the latest updates on subscription trends, listing insights, and GMP, stay tuned to Finowings.

FAQs About Chemkart India IPO

1. What is the Chemkart India IPO GMP today?
As of the latest update, Chemkart India IPO GMP is ₹0, showing a neutral sentiment in the grey market.

2. What is the IPO price band and lot size of Chemkart India?
The price band is ₹236–₹248, and the lot size is 600 shares, requiring a minimum investment of ₹1,48,800.

3. When does the Chemkart India IPO open and close?
The IPO opens on July 7, 2025, and closes on July 9, 2025.

4. On which exchange will Chemkart India IPO list?
Chemkart India IPO will be listed on the BSE SME platform on July 14, 2025.

5. Is Chemkart India IPO a good investment?
With stable fundamentals, a growing B2B model in the nutrition space, and a neutral GMP, it may appeal to long-term investors in the SME segment.